Tools   Select Another Resource Report Type

http://www.cbs.dtu.dk/services/NetOGlyc/

Server that produces predictions of mucin-type GalNAc O-glycosylation sites in mammalian proteins.

Proper citation: NetOGlyc (RRID:SCR_009026) Copy   

•   Source: SciCrunch Registry

https://www.ncbi.nlm.nih.gov/pubmed/18174824

A face-to-face household survey of assessing the prevalence of mental health disorders in a probability sample of 3005 adolescents aged 12-17 years residing in the Mexico City metropolitan area during 2005. The prevalence of mental health disorders and the use of services were assessed with the computer-assisted adolescent version of the World Mental Health Composite International Diagnostic Interview.

Proper citation: Mexican Adolescent Mental Health Survey (RRID:SCR_009654) Copy   

•   Source: SciCrunch Registry

http://purl.bioontology.org/ontology/EHDAA

A structured controlled vocabulary of stage-specific anatomical structures of the human. It has been designed to mesh with the mouse anatomy and incorporates each Carnegie stage of development (CS1-20). The abstract version of the human developmental anatomy ontology compresses all the tissues present over Carnegie stages 1-20 into a single hierarchy. The heart, for example, is present from Carnegie Stage 9 onwards and is thus represented by 12 EHDA IDs (one for each stage). In the abstract mouse, it has a single ID so that the abstract term given as just ''heart'' really means ''heart (CS 9-20)''. Timing details will be added to the abstract version of the ontology in a future release.

Proper citation: Human Developmental Anatomy Ontology abstract version 1 (RRID:SCR_010323) Copy   

•   Source: SciCrunch Registry

http://link.springer.com/article/10.1007%2Fs11357-003-0002-y

A database that stores information on the biomolecules which are modulated during aging and by caloric restriction (CR). To enhance its usefulness, data collected from studies of CR''''s anti-oxidative action on gene expression, oxidative stress, and many chronic age-related diseases are included. AgingDB is organized into two sections A) apoptosis and the various mitochondrial biomolecules that play a role in aging; B) nuclear transcription factors known to be_sensitive to oxidative environment. AgingDB features an imagemap of biomolecular signal pathways and visualized information that includes protein-protein interactions of biomolecules. Authorized users can submit a new biomolecule or edit an existing biomolecule to reflect latest developments.

Proper citation: AgingDB (RRID:SCR_010226) Copy   

•   Source: SciCrunch Registry

http://purl.bioontology.org/ontology/VSO

An extension of the Ontology for General Medical Science (OGMS) that covers the four consensus human vital signs: blood pressure, body temperature, respiration rate, pulse rate. VSO provides also a controlled structured vocabulary for describing vital signs measurement data, the various processes of measuring vital signs, and the various devices and anatomical entities participating in such measurements.

Proper citation: Vital Sign Ontology (RRID:SCR_010446) Copy   

•   Source: SciCrunch Registry

http://purl.bioontology.org/ontology/HINO

An Interaction Network Ontology (INO) extension for the domain of human interaction networks. It has currently incoporated Reactome reactions and pathways. Like INO, HINO aligns with BFO. HINO is developed by following the OBO Foundry principles.

Proper citation: Human Interaction Network Ontology (RRID:SCR_010339) Copy   

•   Source: SciCrunch Registry

http://purl.bioontology.org/ontology/OCRE

Ontology to support systematic description of, and interoperable queries on, human studies and study elements.

Proper citation: Ontology of Clinical Research (RRID:SCR_010392) Copy   

•   Source: SciCrunch Registry

http://purl.bioontology.org/ontology/NCCO

Ontology that contains activities that nurses use while coordinating care among patients.

Proper citation: Nursing Care Coordination Ontology (RRID:SCR_010381) Copy   

•   Source: SciCrunch Registry

http://purl.bioontology.org/ontology/IMMDIS

Ontology generated as part of the Bioinformatics Integration Support Contract (BISC) that is based on the National Library of Medicine (NLM) Medical Subject Headings; National Cancer Institute Thesaurus; International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM); ICD-10; and other open source public databases. Specific information may be available about a class, including Preferred_Name, DEFINITION, Synonym, etc.

Proper citation: Immune Disorder Ontology (RRID:SCR_010344) Copy   

•   Source: SciCrunch Registry

http://www.item.fraunhofer.de/en.html

Institute that offers contract research in the area of human health with a focus on airway research. The institute has pooled its competences to form six business units: Toxicology Testing; Pre-clinical Pharmacology; Early-Phase Clinical Trials; Registration and Risk Assessment; Environmental, Occupational and Consumer Protection; and Manufacturing of Biopharmaceuticals for Clinical Trials. Due to their broad spectrum of expertise, they are able to offer complete solutions from the idea to the product.

Proper citation: Fraunhofer Institute for Toxicology and Experimental Medicine (RRID:SCR_011237) Copy   

•   Source: SciCrunch Registry

http://www.ema.europa.eu/

An agency responsible for the evaluation and supervision of medicines developed by pharmaceutical companies for use in the European Union. Its main responsibility is the protection and promotion of public and animal health through the evaluation and supervision of medicines for human and veterinary use. The Agency also plays a role in stimulating innovation and research in the pharmaceutical sector. The Agency gives scientific advice and other assistance to companies for the development of new medicines. It publishes guidelines on quality-, safety- and efficacy-testing requirements. A dedicated SME Office provides special assistance to small and medium-sized enterprises.

Proper citation: European Medicines Agency (RRID:SCR_011215) Copy   

•   Source: SciCrunch Registry

http://www.marionegri.it/mn/en/

A not-for-profit biomedical research institute whose main aim is to help defend human health and life. Research programs span from the molecular level to the whole human being, and the findings help build up the basis for developing new drugs, and making existing ones more effective. The main research headings are the battle against cancer, nervous and mental illnesses, cardiovascular and kidney diseases, rare diseases and the toxic effects of environmental contaminants, mother and child''''s health. The Institute is also involved in research on pain relief and drug addiction. Parallel to its biomedical investigations, the Mario Negri Institute runs training schemes for laboratory technicians and graduate researchers. It takes part in a range of initiatives to communicate information in biomedicine, on a general level and with the specific aims of improving health care practice, and encouraging more rational use of drugs. There are also research units in Bergamo, at Ranica - near Bergamo - and at Santa Maria Imbaro, near Chieti.

Proper citation: Mario Negri Institute for Pharmacological Research; Milan; Italy (RRID:SCR_011361) Copy   

•   Source: SciCrunch Registry

http://sift.bii.a-star.edu.sg/

Data analysis service to predict whether an amino acid substitution affects protein function based on sequence homology and the physical properties of amino acids. SIFT can be applied to naturally occurring nonsynonymous polymorphisms and laboratory-induced missense mutations. (entry from Genetic Analysis Software) Web service is also available.

Proper citation: SIFT (RRID:SCR_012813) Copy   

•   Source: SciCrunch Registry

http://projectreporter.nih.gov/project_info_description.cfm?aid=8662111&icde=19363315&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC

A multi-center and multi-disciplinary study designed to dramatically increase understanding of chronic traumatic encephalopathy (CTE) and other late effects of traumatic brain injury (TBI). Overlapping clinical features, postmortem pathologies and patterns of involvement exist in TBI, CTE, and Alzheimer''s disease pose challenges to accurate diagnosis. Premortem diagnosis of CTE is currently impossible. The neuropathological consequences of single mild or moderate-severe TBI and its relationship with CTE and known dementias are unclear. The proposed project will leverage extensive resources from an ongoing population-based prospective cohort study of brain aging (Adult Changes in Thought; ACT, n=2,305) which includes excellent medical, behavioral, and genetic characterization of a cohort (20% of whom have a history of mild-moderate TBI) in addition to state-of-the-art neuropathology workup upon death. Neuropathological study of TBI effects can begin immediately in the existing ACT autopsy sample (n=489, 20% with TBI exposure). Additional cohorts of TBI- exposed individuals will come from the Brain Injury Research Center at Mount Sinai (n=150 individuals with moderate-severe TBI), the University of Texas Southwestern (n=50 retired boxers with repetitive TBI exposure), and the National Football League (n=76 retired players with repetitive TBI exposure). All participants in the proposed study (ACT and other sites) will undergo uniform harmonized neurobehavioral assessment (chosen to maximize correspondence with existing large-scale TBI and dementia studies), MRI scan, and genomic analysis. Those individuals who expire during the course of the study will undergo ex-vivo neuroimaging and extensive neuropathological exam using state-of-the-art techniques (such as Histelide) designed to quantify tau and A�� in whole brain specimens. Only by examining postmortem pathology in a sample of individuals with varying levels of TBI exposure who are well characterized during life (as proposed herein) can postmortem pathology facilitate identification of in-vivo biomarkers that can act as diagnostic tools. This project represents the most systematic and scientifically rigorous effort to date to develop a more complete understanding of the long-term clinical and neuropathological sequelae of single and multiple TBI.

Proper citation: Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo Diagnostics (RRID:SCR_012951) Copy   

•   Source: SciCrunch Registry

http://commonfund.nih.gov/GTEx/

Project to study human gene expression and regulation in multiple tissues, providing valuable insights into mechanisms of gene regulation and its disease related perturbations. Genetic variation between individuals will be examined for correlation with differences in gene expression level to identify regions of the genome that influence whether and how much a gene is expressed. Includes initiatives: Novel Statistical Methods for Human Gene Expression Quantitative Trait Loci (eQTL) Analysis ,Laboratory, Data Analysis, and Coordinating Center (LDACC), caHUB Acquisition of Normal Tissues in Support of GTEx Project.

Proper citation: Genotype-Tissue Expression (RRID:SCR_013042) Copy   

•   Source: SciCrunch Registry

http://mouse.brain-map.org/static/brainexplorer

Atlas of the brain and the disorders affecting it, aimed at general practitioners and specialists in training. It consists of three main parts: a description of the different parts of the normal brain and their functions, a description of the process of neurological control, and a description of 14 different brain disorders in psychiatry and neurology - as well as their cause, symptoms, and treatment.

Proper citation: Brain Explorer Atlas and Teaching Tool (RRID:SCR_013022) Copy   

•   Source: SciCrunch Registry

http://www.bio-vault.com/humantissuebank

Private human tissue processing and storage bank in the UK based in Plymouth on the medical campus of Derriford Hospital, Europe''s 4th largest teaching hospital. The company was set up to serve the UK and private health sectors looking to outsource the processing and storage of human tissue to an accredited, trusted and experienced expert. Storing for human application, they now process and store human tissue for organizations all over the world, including the Plymouth Hospitals NHS Trust. They are also the only private tissue bank of any true scale in the UK with the ability to store well over 1 million human tissue samples on one site. BioVault has achieved a number of accreditations and forged relationships with numerous bodies since 2002, all designed to test the robustness of our internal procedures and reassure clients they are being given the highest levels of quality and service. Many of BioVault''s pioneering systems have been designed to exceed the criteria set out by the Human Tissue Authority (HTA) with whom we work closely. The HTA is the competent authority under the European Tissue and Cell Directive and sets the standards for regulating human tissue application establishments.

Proper citation: BioVault (RRID:SCR_004339) Copy   

•   Source: SciCrunch Registry

https://www.ucl.ac.uk/biobank/physicalbloom

The UCL/UCLH Biobank for Studying Health and Disease has been primarily established to support the Research Programme and scientific needs, of the Pathology Department UCLH & the UCL Cancer Institute. The establishment of the core programme enables a centralised approach to the management and integration of all research groups working within these institutions, providing appropriate structure and support. The biobank has policies and guidelines to guarantee compliance with HTA legislation and to ensure quality standards will be maintained. The biobank stores normal and pathological specimens, surplus to diagnostic requirements, from relevant tissues and bodily fluids, as well as human tissue used in xenograft experiments. Stored tissues include; snap-frozen or cryopreserved tissue, formalin-fixed tissue, paraffin-embedded tissues, and slides prepared for histological examination. Tissues include resection specimens obtained surgically or by needle core biopsy. Bodily fluids include; whole blood, serum, plasma, urine, cerebrospinal fluid, milk, saliva and buccal smears and cytological specimens such as sputum and cervical smears. Fine needle aspirates obtained from tissues and bodily cavities (eg. pleura and peritoneum) are also collected. Where appropriate the biobank also stores separated cells, protein, DNA and RNA isolated from collected tissues and bodily fluids described above. Some of the tissue and aspirated samples are stored in the diagnostic archive.

Proper citation: UCL/UCLH Biobank for Studying Health and Disease (RRID:SCR_004610) Copy   

•   Source: SciCrunch Registry

http://www.biobanque-picardie.com/index_En.php

A secure repository of biological samples and data dedicated for medical and research purposes. These biological samples are linked to consenting patient relative data. Biobanque de Picardie provides quality and traceability services for establishment, conservation and use of biological samples collections. It houses collections of human tissue in a variety of areas of disease. Samples are used in basic research and translational studies, physiopathology of diseases and identification of new diagnostic, and as prognostic or therapeutic biomarkers. Biobanque de Picardie also develops healthy or pathological human primary stem cell banks, such as: mesenchymal stem cells in umbilical cord (HUC-MSC), primary hepatocytes (HPH), peripheral blood mononuclear cells (PBMC), and fibroblasts. Biological samples are stored at - 80 degrees C in electric freezers, at - 196 degrees C in liquid nitrogen or -130 degrees C in nitrogen vapor.

Proper citation: Biobanque de Picardie (RRID:SCR_004731) Copy   

•   Source: SciCrunch Registry

http://www.sciencecare.com/

Science Care''s whole body donation program supports medical research, training and professional education, which provides enormous benefits to humankind. Given the increasing advancements in medical technologies, donation is of greater importance than ever. A life-affirming choice, donation is also a highly individual decision. In every way possible, Science Care honors that decision by adhering to the strictest guidelines and providing the most compassionate care. Science Care was founded in 2000 with the vision to become the world''s leading whole body donor program. Under the leadership of James Rogers, Founder and CEO, Science Care has accelerated research on many fronts leading to the development of new medical devices and safer, more effective treatments for patients. At Science Care, we provide the opportunity to make a final choice with control and dignity. Our donors know that their last act was donating to the welfare of humankind, and their gift provides a lasting legacy.

Proper citation: ScienceCare (RRID:SCR_004457) Copy   

•   Source: SciCrunch Registry